Trials / Completed
CompletedNCT04680520
Barrier Enhancement for Eczema Prevention
A Randomised Controlled Trial to Determine Whether Application of Emollient From Birth Can Prevent Eczema in High Risk Children.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,394 (actual)
- Sponsor
- University of Nottingham · Academic / Other
- Sex
- All
- Age
- 21 Days
- Healthy volunteers
- Accepted
Summary
The primary objective is to determine whether advising parents to apply emollient (moisturiser) to their child's skin for the first year of life in addition to best practice infant skin care advice can prevent or delay the onset of eczema in high-risk children, when compared with a control group who are given the best practice infant skin care advice only.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental (Doublebase Gel® or Diprobase Cream®) | Emollient (Doublebase Gel® or Diprobase Cream®) use on the skin. The emollient should be applied at least once a day. |
| OTHER | Best practice skin care advice booklet | This is a booklet containing advice on best practice skin care. This will contain information on avoiding soap etc. |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2018-12-01
- Completion
- 2022-01-01
- First posted
- 2020-12-23
- Last updated
- 2022-11-28
Locations
16 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04680520. Inclusion in this directory is not an endorsement.